Publication Information

{'id': 'https://openalex.org/W2363471437', 'doi': None, 'title': 'Developments of topoisomerase I inhibitors in cancer chemotherapy', 'display_name': 'Developments of topoisomerase I inhibitors in cancer chemotherapy', 'publication_year': 2007, 'publication_date': '2007-01-01', 'ids': {'openalex': 'https://openalex.org/W2363471437', 'mag': '2363471437'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200713004.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765031496', 'display_name': 'Zhongguo xin yao zazhi', 'issn_l': '1003-3734', 'issn': ['1003-3734'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323253388', 'host_organization_name': 'Chinese Journal of New Drugs Co. Ltd.', 'host_organization_lineage': ['https://openalex.org/P4323253388'], 'host_organization_lineage_names': ['Chinese Journal of New Drugs Co. Ltd.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5089348951', 'display_name': 'Jian Ding', 'orcid': 'https://orcid.org/0000-0002-5815-4956'}, 'institutions': [{'id': 'https://openalex.org/I19820366', 'display_name': 'Chinese Academy of Sciences', 'ror': 'https://ror.org/034t30j35', 'country_code': 'CN', 'type': 'government', 'lineage': ['https://openalex.org/I19820366']}, {'id': 'https://openalex.org/I4210112820', 'display_name': 'Shanghai Institute of Materia Medica', 'ror': 'https://ror.org/022syn853', 'country_code': 'CN', 'type': 'facility', 'lineage': ['https://openalex.org/I19820366', 'https://openalex.org/I4210112820']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Ding Jian', 'raw_affiliation_strings': ['Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.'], 'affiliations': [{'raw_affiliation_string': 'Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.', 'institution_ids': ['https://openalex.org/I19820366', 'https://openalex.org/I4210112820']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5089348951'], 'corresponding_institution_ids': ['https://openalex.org/I19820366', 'https://openalex.org/I4210112820'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.388431, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 63, 'max': 70}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9828, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12172', 'display_name': 'Neutropenia and Cancer Infections', 'score': 0.9695, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/topoisomerase-inhibitor', 'display_name': 'Topoisomerase inhibitor', 'score': 0.45560968}], 'concepts': [{'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.9158796}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.57082576}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5181114}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.49181774}, {'id': 'https://openalex.org/C2778616834', 'wikidata': 'https://www.wikidata.org/wiki/Q281044', 'display_name': 'Topoisomerase inhibitor', 'level': 4, 'score': 0.45560968}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.41037893}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40848207}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.32176796}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.25449377}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.14117914}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.071344465}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200713004.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765031496', 'display_name': 'Zhongguo xin yao zazhi', 'issn_l': '1003-3734', 'issn': ['1003-3734'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323253388', 'host_organization_name': 'Chinese Journal of New Drugs Co. Ltd.', 'host_organization_lineage': ['https://openalex.org/P4323253388'], 'host_organization_lineage_names': ['Chinese Journal of New Drugs Co. Ltd.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3152458788', 'https://openalex.org/W2867070826', 'https://openalex.org/W2805822661', 'https://openalex.org/W2606222048', 'https://openalex.org/W2592608502', 'https://openalex.org/W2474064651', 'https://openalex.org/W2469477907', 'https://openalex.org/W2467107235', 'https://openalex.org/W2393222887', 'https://openalex.org/W2367757019', 'https://openalex.org/W2347506953', 'https://openalex.org/W2344056970', 'https://openalex.org/W2073551523', 'https://openalex.org/W2068460621', 'https://openalex.org/W2026709688', 'https://openalex.org/W2012099747', 'https://openalex.org/W2009323563', 'https://openalex.org/W1988086962', 'https://openalex.org/W184874732', 'https://openalex.org/W1485383'], 'abstract_inverted_index': {'Following': [0], 'the': [1], 'realization': [2], 'that': [3, 25], 'human': [4], 'DNA': [5], 'topoisomerase': [6], 'Ⅰ(Topo': [7], 'Ⅰ)': [8], 'is': [9], 'a': [10, 20], 'useful': [11], 'therapeutic': [12], 'target': [13], 'against': [14], 'tumor': [15], 'growth,Topo': [16], 'Ⅰ': [17, 36, 57], 'inhibitors': [18, 37, 58], 'represent': [19], 'class': [21], 'of': [22, 55, 70], 'effective': [23], 'agents': [24, 61], 'have': [26], 'been': [27], 'extensively': [28], 'exploited': [29], 'and': [30, 47, 53, 67], 'used': [31, 40], 'for': [32], 'carcinoma': [33], 'chemotherapy.Current': [34], 'Topo': [35, 56], 'being': [38], 'clinically': [39], 'or': [41], 'developed': [42], 'are': [43], 'classified': [44], 'as': [45, 59], 'campotothecins': [46], 'non-camptothecins.This': [48], 'presentation': [49], 'introduces': [50], 'current': [51], 'status': [52], 'trends': [54], 'anti-tumor': [60], 'with': [62], 'an': [63], 'emphasis': [64], 'on': [65], 'bioactive': [66], 'pharmacological': [68], 'properties': [69], 'these': [71], 'agents.': [72]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2363471437', 'counts_by_year': [{'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-15T14:42:42.669715', 'created_date': '2016-06-24'}